Aquestive Therapeutics Inc

NASDAQ:AQST   3:56:29 PM EDT
3.47
+0.04 (+1.17%)
Other Pre-Announcement

Aquestive Therapeutics Reports Q1 Financial Results And Provides Business Update

Published: 05/05/2021 01:29 GMT
Aquestive Therapeutics Inc (AQST) - Aquestive Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update.
Q1 Revenue $11.1 Million.
Sees 2021 Non-GAAP Adjusted EBITDA Loss of Approximately $42 Million to $45 Million.
Sees 2021 Non-GAAP Adjusted Gross Margins of Approximately 70% to 75% on Total Revenues.
Aquestive Therapeutics - Sees 2021 Total Revenues of Approximately $38 Million to $42 Million.
Aquestive Therapeutics - Qtrly Net Loss per Share Basic and Diluted $0.41.
Q1 Earnings per Share View $-0.43 -- Refinitiv Ibes Data (analyst estimates).
Q1 Revenue View $9.0 Million -- Refinitiv Ibes Data (analyst estimates).
FY2021 Revenue View $39.1 Million -- Refinitiv Ibes Data (analyst estimates).